blocked the Hh signaling pathway by inhibiting the important effectors of this pathway, such as SHH, SMO, Gli-1, and SDF-1 (CXCL12) , inhibited desmoplasia and interrupted the tumor–stromal interactions. The gene discussed is SMO; the disease is neoplasm.